Maker of GLP1 pens scales up for generic debuts

As weight-loss drug sales surge with semaglutide's patent expiration, Gujarat's Shaily Engineering Plastics, an injector pen manufacturer, anticipates significant growth. Its stock has nearly doubled, and the company is doubling its production capacity to 80-85 million pens by fiscal year-end to meet rising domestic and export demands.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yGJ7CbR
via IFTTT